ARCHIVES

Georgetown Names Cullen Interim Center Director.

This article is from The Cancer Letter archive.

Vol. 26 No. 40 | November 3, 2000

Download PDF Visit The Full Archive

Related Articles

IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC

March 28, 2014

Cancer Groups Propose Six Characteristics Of Next FDA Head.

December 19, 2008

Institute of Medicine Elects 70 Members at Annual Meeting

October 25, 2013

SEC Notifies ImClone It May Bring Action Against Company

June 21, 2002

NCA Okays New Centers Category For Environmental Carcinogenesis

July 4, 1975

Oncologist Urge FDA to Allow Cancer Patients Access to Silicone Implants, But Continue Study

March 6, 1992